{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:48:35Z","timestamp":1787161715696,"version":"build-2736575974"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The VARIVAX\u00ae Pregnancy Registry was established in 1995 to monitor pregnancy outcomes of women who received varicella vaccine (ie, VARIVAX) inadvertently while pregnant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Health care providers and consumers sent voluntary reports about women who received VARIVAX 3 months before or during pregnancy. Follow-up occurred to evaluate pregnancy outcomes for birth defects. Outcomes from prospectively reported pregnancy exposures (ie, reports received before the outcome of the pregnancy was known) among varicella-zoster virus (VZV)-seronegative women were used to calculate rates and 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 17 March 1995 through 16 October 2013, 1601 women were enrolled\u2014966 prospectively\u2014among whom there were 819 live births. Among 164 infants born to women who were VZV seronegative at the time of vaccination, no cases of congenital varicella syndrome (CVS) were identified (rate, 0 per 100, 95% CI, 0.0\u20132.2) and the birth prevalence of major birth defects was 4.3 per 100 liveborn infants (95% CI 1.7\u20138.6) with no pattern suggestive of CVS. No defects consistent with CVS were identified in any registry reports.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Data collected through the VARIVAX pregnancy registry do not support a relationship between the occurrence of CVS or major birth defects and varicella vaccine exposure during pregnancy, although the small numbers of exposures cannot rule out a low risk. VARIVAX remains contraindicated during pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiac277","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T11:52:13Z","timestamp":1661341933000},"page":"S441-S449","source":"Crossref","is-referenced-by-count":10,"title":["Merck\/Centers for Disease Control and Prevention Varicella Vaccine Pregnancy Registry: 19-Year Summary of Data From Inception Through Closure, 1995\u20132013"],"prefix":"10.1093","volume":"226","author":[{"given":"English D","family":"Willis","sequence":"first","affiliation":[{"name":"Merck & Co, Inc , Rahway, New Jersey , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M","family":"Marko","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc , Rahway, New Jersey , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja A","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Office of Infectious Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"McGee","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc , Rahway, New Jersey , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R","family":"Broder","sequence":"additional","affiliation":[{"name":"Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Marin","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"2022102100075618800_jiac277-B1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM194704102361504","article-title":"Multiple congenital defects following maternal varicella; report of a case","volume":"236","author":"Laforet","year":"1947","journal-title":"N Engl J Med"},{"key":"2022102100075618800_jiac277-B2","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0140-6736(94)92943-2","article-title":"Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases","volume":"343","author":"Enders","year":"1994","journal-title":"Lancet"},{"key":"2022102100075618800_jiac277-B3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.15585\/mmwr.mm7110a5","article-title":"Notes from the field: congental varicella case, Illinois, 2021","volume":"71","author":"Leung","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022102100075618800_jiac277-B4","first-page":"708","volume-title":"Birth defects encyclopedia 1990","author":"Roberts","year":"1990"},{"key":"2022102100075618800_jiac277-B5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-3476(79)80354-6","article-title":"Congenital skin ulcers following varicella in late pregnancy","volume":"94","author":"Bai","year":"1979","journal-title":"J Pediatr"},{"key":"2022102100075618800_jiac277-B6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00006454-199206000-00023","article-title":"Congenital anomalies resulting from maternal varicella at 25 1\/2 weeks of gestation","volume":"11","author":"Salzman","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"2022102100075618800_jiac277-B7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.reprotox.2005.04.011","article-title":"Chickenpox in pregnancy: revisited","volume":"21","author":"Tan","year":"2006","journal-title":"Reprod Toxicol"},{"key":"2022102100075618800_jiac277-B8","first-page":"1","article-title":"Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"2022102100075618800_jiac277-B9","first-page":"1","article-title":"Varicella vaccination two-doses recommendations","volume":"36","author":"National Advisory Committee on Immunization (NACI)","year":"2010","journal-title":"Can Commun Dis Rep"},{"key":"2022102100075618800_jiac277-B10","author":"Merck Sharp & Dohme Corp","year":"2021"},{"key":"2022102100075618800_jiac277-B11","author":"Merck Canada, Inc","year":"2020"},{"key":"2022102100075618800_jiac277-B12","first-page":"869","volume-title":"Red book: 2018 report of the committee on infectious diseases","author":"American Academy of Pediatrics","year":"2018","edition":"31st ed"},{"key":"2022102100075618800_jiac277-B13","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/AOG.0000000000003013","article-title":"American College of Obstetricians and Gynecologists committee opinion No. 762: Prepregnancy counseling","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2022102100075618800_jiac277-B14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S1701-2163(16)34354-7","article-title":"Immunization in pregnancy","volume":"31","author":"Gruslin","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"2022102100075618800_jiac277-B15","author":"Government of Canada","year":"2018"},{"key":"2022102100075618800_jiac277-B16","first-page":"239","article-title":"Establishment of VARIVAX pregnancy registry","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022102100075618800_jiac277-B17","first-page":"14","article-title":"Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry","volume":"98","author":"Shields","year":"2001","journal-title":"Obstet Gynecol"},{"key":"2022102100075618800_jiac277-B18","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/522136","article-title":"Varicella vaccine exposure during pregnancy: data from 10 years of the pregnancy registry","volume":"197","author":"Wilson","year":"2008","journal-title":"J Infect Dis"},{"key":"2022102100075618800_jiac277-B19","author":"Cunningham","year":"2010","journal-title":"Williams obstetrics,"},{"key":"2022102100075618800_jiac277-B20","author":"Centers for Disease Control and Prevention"},{"key":"2022102100075618800_jiac277-B21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/bdra.20508","article-title":"Including prenatal diagnoses in birth defects monitoring: Experience of the metropolitan Atlanta congenital defects program","volume":"85","author":"Cragan","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2022102100075618800_jiac277-B22","volume-title":"Modeling binary data","author":"Collet","year":"2003","edition":"2nd ed"},{"key":"2022102100075618800_jiac277-B23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable inference, the law of succession, and statistical inference","volume":"22","author":"Wilson","year":"1927","journal-title":"J Am Stat Assoc"},{"key":"2022102100075618800_jiac277-B24","first-page":"595","volume-title":"Pharmacoepidemiology","author":"Mitchell","year":"1994"},{"key":"2022102100075618800_jiac277-B25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1542\/peds.105.1.136","article-title":"Committee on Infectious Diseases. Varicella vaccine update","volume":"105","year":"2000","journal-title":"Pediatrics"},{"key":"2022102100075618800_jiac277-B26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/003335490712200411","article-title":"Validity of self-reported varicella disease history in pregnant women attending prenatal clinics","volume":"122","author":"Watson","year":"2007","journal-title":"Public Health Rep"},{"key":"2022102100075618800_jiac277-B27","volume-title":"Langman's medical embryology","author":"Sadler","year":"2011","edition":"12th ed"},{"key":"2022102100075618800_jiac277-B28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/pds.749","article-title":"Pharmacoepidemiologic implications of erroneous varicella vaccinations in pregnancy through confusion with varicella zoster immune globulin","volume":"11","author":"Wise","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022102100075618800_jiac277-B29","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiac221","article-title":"Monitoring varicella vaccine impact on varicella incidence in the United States: surveillance challenges and changing epidemiology, 1995\u20132019","author":"Marin","year":"2022","journal-title":"J Infect Dis"},{"key":"2022102100075618800_jiac277-B30","first-page":"1","article-title":"Update on overall prevalence of major birth defects\u2014Atlanta, Georgia, 1978\u20132005","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022102100075618800_jiac277-B31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0163-4453(98)80152-7","article-title":"Fetal varicella syndrome\u2014a reappraisal of the literature. A review prepared for the UK advisory group on chickenpox on behalf of the British Society for the Study of Infection","volume":"36","author":"Birthistle","year":"1998","journal-title":"J Infect"},{"key":"2022102100075618800_jiac277-B32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/bdra.10012","article-title":"Guidelines for case classification for the national birth defects prevention study","volume":"67","author":"Rasmussen","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2022102100075618800_jiac277-B33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bdr2.1096","article-title":"Malformations surveillance: comparison between findings at birth and age 1 year","volume":"110","author":"Thomas","year":"2018","journal-title":"Birth Defects Res"},{"key":"2022102100075618800_jiac277-B34","first-page":"732","article-title":"Closure of varicella-zoster virus-containing vaccines pregnancy registry\u2014United States, 2013","volume":"63","author":"Marin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022102100075618800_jiac277-B35","author":"Centers for Disease Control and Prevention and the Food and Drug Administration"},{"key":"2022102100075618800_jiac277-B36","author":"Government of Canada"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/226\/Supplement_4\/S441\/46582580\/jiac277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/226\/Supplement_4\/S441\/46582580\/jiac277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T20:11:50Z","timestamp":1666296710000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/226\/Supplement_4\/S441\/6764828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":36,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2022,10,21]]},"published-print":{"date-parts":[[2022,10,21]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiac277","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,10,21]]}}}